By Matt Harrington, BCBA · Behaviorist Book Club · April 2026 · 12 min read

Payor Reimbursement for Behavioral Health Providers: Using Transparency Data to Maximize Contracts and Protect Your Practice

Overview & Clinical Significance

Behavioral health providers — including ABA practices — operate in a reimbursement environment that has historically undervalued their services relative to other healthcare specialties and relative to the actual cost of delivering high-quality care. Insurance reimbursement rates directly affect the clinical resources available to practices: the ability to hire and retain qualified BCBAs, maintain manageable caseload ratios, invest in supervision infrastructure, and sustain the intensity of services that effective ABA requires. When reimbursement is inadequate, clinical quality is not far behind.

Dan Schwarzlander's presentation addresses the increasingly important role of healthcare pricing transparency data in payor negotiations for behavioral health organizations. The Centers for Medicare and Medicaid Services (CMS) now require hospitals and insurers to disclose negotiated rates for covered services — information that was previously considered proprietary. This transparency data, when analyzed effectively, provides behavioral health practices with comparative rate benchmarks that were previously unavailable and that significantly strengthen their negotiating position.

For BCBAs in practice ownership or administrative roles, this is highly practical information. Understanding whether your current contracted rates are above, at, or below market rates for your geography is foundational to any strategic payor negotiation. Practices that negotiate from a position of data have consistently better outcomes than practices that negotiate on advocacy alone. The transparency data does not eliminate the complexity of payor negotiations, but it removes the information asymmetry that insurers have historically exploited.

This course is also clinically significant because reimbursement issues are not purely business matters — they directly affect access to care for individuals with ASD and other behavioral health needs. A practice that cannot sustain itself financially cannot serve its clients. BCBAs who understand the reimbursement landscape and can contribute to securing adequate funding for their organization are contributing to client welfare in a way that is every bit as important as their direct clinical work.

Background & Context

Behavioral health reimbursement has been chronically depressed relative to medical and surgical services, a disparity that has been the subject of mental health parity legislation for decades. The Mental Health Parity and Addiction Equity Act (MHPAEA) and its subsequent amendments have attempted to require that behavioral health benefits be no more restrictive than medical or surgical benefits — but enforcement has been inconsistent and the practical impact on ABA reimbursement has been limited.

The CMS price transparency rules represent a different kind of regulatory development. Rather than mandating rate parity, they mandate information disclosure: insurers must publish their negotiated rates for covered services in machine-readable formats. This has created a new data ecosystem that market analysis firms have organized into searchable databases — enabling providers to look up what competing practices in their geography are being paid for the same CPT codes under the same payor contracts.

For ABA practices specifically, the relevant CPT codes — primarily 97151-97158 for assessment and treatment — are now visible in this data. Practices can use this information to determine whether they are being reimbursed below market rates, to identify payors with particularly high or low market rates, and to build a data-supported case for rate increases during contract negotiations or renegotiations. This is a significant shift in the information environment that ABA practice leaders need to understand.

The broader context of value-based care is also relevant here. The transition from fee-for-service reimbursement to value-based models — where providers are paid based on outcomes rather than volume — is progressing unevenly in behavioral health. ABA practices that can demonstrate clinical outcomes with data are better positioned in this environment than those that rely on service volume alone. Understanding both the current fee-for-service reimbursement environment and the trajectory toward value-based models is essential for long-term strategic planning.

Clinical Implications

The connection between reimbursement rates and clinical quality is not merely theoretical. ABA practices operating under inadequate reimbursement consistently make clinical compromises: increasing caseload sizes, reducing supervision hours, relying on less experienced staff, or decreasing the frequency and intensity of services. Each of these compromises has direct, measurable clinical consequences. BCBAs who understand the reimbursement landscape are better positioned to advocate for the organizational resources that their clinical programs require.

CPT code optimization is one area where understanding reimbursement intersects with clinical practice in a concrete way. The CPT codes for ABA services differentiate between protocol modification, direct treatment, and parent training, among other service types. BCBAs who understand the billing implications of their documentation are better positioned to ensure that the services they provide are billed accurately — which both ensures appropriate reimbursement and protects the practice from audit risk. Accurate, CPT-aligned documentation is both a clinical and a compliance responsibility.

Carve-out arrangements — where behavioral health benefits are administered by a separate managed behavioral health organization (MBHO) rather than the primary medical insurer — create specific clinical challenges for ABA practices. Carve-out payors often apply more restrictive medical necessity criteria than the primary medical payor, creating access barriers for clients whose ABA is carved out to an MBHO. BCBAs in administrative roles should understand which of their payor contracts involve carve-outs and how this structure affects both authorization processes and reimbursement rates.

Finally, the transition to value-based contracts has direct clinical implications. Under value-based models, practices may be required to demonstrate clinical outcomes data to justify reimbursement — a requirement that is entirely consistent with behavior analytic practice but that requires robust data systems, defined outcome measures, and the ability to aggregate and report data across caseloads. BCBAs who already maintain rigorous data systems are well-positioned for this transition; those who do not will face both clinical and financial risk.

Ethical Considerations

Payor reimbursement is an ethical issue for BCBAs, not just a business one. Code 2.01 (Providing Effective Treatment) requires BCBAs to advocate for the resources necessary to deliver effective treatment. When reimbursement rates are so low that they prevent practices from maintaining adequate staffing, supervision, and program quality, BCBAs have an ethical obligation to address those conditions — including through payor negotiation. Accepting inadequate reimbursement without advocacy is not ethically neutral.

Code 7.01 (Accurate Billing and Financial Reporting) is directly relevant to the reimbursement discussion. BCBAs must ensure that billing accurately reflects the services provided, that documentation supports the codes billed, and that there is no upcoding, unbundling, or other billing manipulation. The transparency data environment makes compliance more important than ever: rate disparities that come to insurers' attention may trigger audits that examine both contracted rates and billing patterns. Billing integrity is both an ethical requirement and a risk management priority.

Code 6.01 (Compliance with Laws and Regulations) requires BCBAs and their organizations to comply with all applicable laws, including the price transparency regulations and the billing and coding rules that govern ABA services. BCBAs in administrative roles should ensure that their organizations have appropriate compliance infrastructure — including billing audits, documentation reviews, and staff training on CPT code application — to maintain regulatory compliance as the reimbursement environment evolves.

Code 5.04 (Maintaining Records) is relevant in the context of payor negotiations. Practices that maintain thorough records of their payor contract history, rate negotiation outcomes, prior authorizations, and billing data are better positioned to support rate negotiation conversations with data and to defend their positions if a dispute with an insurer arises. Records management in ABA practices must encompass not just clinical records but the financial and contractual records that support business operations.

Assessment & Decision-Making

A systematic approach to payor reimbursement analysis begins with a rate benchmarking exercise. Using transparency data, BCBAs and practice administrators should pull the negotiated rates for the key ABA CPT codes from each of their payor contracts and compare them to the rates reported for similar providers in their geographic market. This analysis reveals which contracts are above market, which are at market, and which are below market — providing the data foundation for renegotiation priority-setting.

Not all below-market contracts are equally addressable. Factors that influence renegotiation opportunity include the proportion of your practice revenue that comes from the payor (higher volume = greater leverage), the payor's market share in your geography (dominant payors have less competitive pressure to increase rates), your practice's clinical outcomes data (demonstrable outcomes support a value-based rate argument), and the contract's escalator provisions (some contracts include automatic annual rate adjustments that reduce the need for active negotiation).

The decision to pursue rate renegotiation requires an ROI analysis. Negotiation takes time, and the outcome is not guaranteed. Practices should calculate the financial impact of a rate increase at various levels (e.g., a 5%, 10%, or 15% increase in rates across a given payor's volume) and compare this to the cost of the negotiation effort. This analysis helps prioritize which contracts warrant active renegotiation and which are better managed through other strategies such as volume optimization or payor mix diversification.

Carve-out and value-based care transitions each require their own decision frameworks. For carve-outs, the key question is whether the MBHO's rates and authorization processes are compatible with providing effective ABA services to your clients. For value-based transitions, the question is whether your clinical data systems are ready to support outcomes-based contracting and what investments in data infrastructure might be needed to participate effectively in these arrangements.

What This Means for Your Practice

If you are in a practice ownership, administrative, or clinical leadership role in an ABA organization, the transparency data ecosystem described in this course represents a genuine competitive and strategic resource. The first practical step is to access the transparency data for your key payor contracts and conduct a rate benchmarking analysis. Several market analytics platforms have organized this data into searchable formats that make benchmarking feasible without requiring extensive data science capabilities.

Once you have your benchmarking data, you can develop a negotiation priority matrix: which payors offer the greatest opportunity for rate improvement, which have the least room for negotiation given market dynamics, and which represent risk to the practice if the relationship deteriorates. This matrix should inform your contracting calendar — when to initiate renegotiation conversations, when to simply monitor the market, and when to consider whether participation in a specific contract is economically viable.

For clinical leaders who are not in administrative roles, this content is still relevant because understanding the reimbursement environment helps you advocate effectively for the clinical resources your programs require. When you understand why your organization makes certain staffing or supervision decisions, you can engage in those conversations more productively. And when reimbursement constraints are affecting the quality of care you can provide, you can name that connection explicitly in conversations with practice leadership.

Building a culture of financial literacy alongside clinical excellence in ABA organizations produces practices that are both clinically excellent and economically sustainable — which, ultimately, is the only way to ensure that the individuals and families who need ABA services will have access to high-quality programs for the long term.